Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688608 | SCV000816228 | likely benign | Retinoblastoma | 2024-04-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440436 | SCV002677743 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-11-08 | criteria provided, single submitter | clinical testing | The p.P28L variant (also known as c.83C>T), located in coding exon 1 of the RB1 gene, results from a C to T substitution at nucleotide position 83. The proline at codon 28 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |
Gene |
RCV003117490 | SCV003798578 | uncertain significance | not provided | 2022-08-03 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23516486) |
All of Us Research Program, |
RCV000688608 | SCV004834483 | uncertain significance | Retinoblastoma | 2024-01-11 | criteria provided, single submitter | clinical testing |